Severe Leukocyte Adhesion Deficiency

Gene Therapy Restores Immune Function in Children with Rare Disorder

A groundbreaking trial using lentiviral gene therapy has enabled nine children with severe LAD-1 to survive and thrive, with the treatment now under FDA review.